Stifel Financial
DTIL icon

Stifel Financial’s Precision BioSciences DTIL Stock Holding History

Stifel Financial’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
+14,020
New +$98.7K ﹤0.01% 3606
2024
Q4 		– Sell
-21,270
Closed -$191K – 3408
2024
Q3 		$191K Sell
21,270
-9,185
-30% -$88.4K ﹤0.01% 3152
2024
Q2 		$296K Sell
30,455
-9,416
-24% -$111K ﹤0.01% 2923
2024
Q1 		$541K Sell
39,871
-11,657
-23% -$143K ﹤0.01% 2563
2023
Q4 		$564K Buy
51,528
+733
+1% +$7.9K ﹤0.01% 2498
2023
Q3 		$520K Sell
50,795
-14,501
-22% -$223K ﹤0.01% 2467
2023
Q2 		$1.03M Buy
65,296
+34,993
+115% +$800K ﹤0.01% 2069
2023
Q1 		$685K Sell
30,303
-1,144
-4% -$37.7K ﹤0.01% 2324
2022
Q4 		$1.12M Buy
31,447
+8,246
+36% +$326K ﹤0.01% 1906
2022
Q3 		$905K Sell
23,201
-955
-4% -$45.4K ﹤0.01% 2040
2022
Q2 		$1.16M Buy
24,156
+20,209
+512% +$1.19M ﹤0.01% 1891
2022
Q1 		$365K Buy
+3,947
New +$536K ﹤0.01% 2752

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Stifel Financial's DTIL Position: Q2 2026 in Review

Stifel Financial opened a new position in Precision BioSciences (DTIL) in Q2 2026: 14,020 shares worth $110K. The stake represents ﹤0.01% of the portfolio and ranks #3606 among its holdings. This is a return to the name: Stifel Financial previously reported a position in DTIL as recently as Q3 2024.

Stifel Financial first reported a position in DTIL in Q1 2022 and has held it in 12 quarters since. The position peaked at $1.16M in Q2 2022. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Stifel Financial held 14,020 shares of Precision BioSciences worth $110K as of Q2 2026.
  • Precision BioSciences was a new Stifel Financial position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3606 holding.
  • Stifel Financial first reported a position in Precision BioSciences in Q1 2022 and has held it in 12 quarters since.
  • Stifel Financial's Precision BioSciences position peaked at $1.16M in Q2 2022.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.